Skip to main content
. 2023 May 15;12(12):13599–13609. doi: 10.1002/cam4.6057

FIGURE 2.

FIGURE 2

Mendelian randomization (MR) results for European population, with HCC, CCA, and PC as outcomes. IBD, inflammatory bowel disease; CD, crohn's disease; UC, ulcerative colitis; HCC, hepatocellular carcinoma; CCA, cholangiocarcinoma; PC, pancreatic cancer; IVs, instrumental variables; IVW, inverse‐variance weighted; OR, odds ratio; 95% CI, 95% confidence interval.